Novo Nordisk A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 13/05/2026 BST			5-day change	1st Jan Change
299.20 ^DKK	+0.91%		+1.25%	-8.01%

05-15	European Equities Traded in the US as American Depositary Receipts Down Sharply in Friday Trading	MT
05-15	Sandoz Lands EU Nod for Insulin Biosimilars Bysumlog, Dazparda	MT

Published on 11/06/2024 at 12:00 pm GMT

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good day, and thank you for standing by. Welcome to the Third Quarter 2024 Novo Nordisk A/S Earnings Conference Call. [Operator Instructions]

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

05-15	European Equities Traded in the US as American Depositary Receipts Down Sharply in Friday Trading	MT
05-15	Sandoz Lands EU Nod for Insulin Biosimilars Bysumlog, Dazparda	MT
05-15	Baillie Gifford European repositions portfolio as asset value falls	AN
05-14	European Equities Traded in the US as American Depositary Receipts Tracking Higher in Thursday Trading	MT
05-13	Takeda to cut about 4,500 jobs in fiscal 2026 as it steps up restructuring	RE
05-13	Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Wednesday Ahead of US-China Meeting	MT
05-13	Novo Nordisk Canada and Rexall Pharmacy partner to offer convenience, support, and home delivery for Canadians taking Ozempic and Wegovy	RE
05-13	Novo Nordisk Says Wegovy Pill Delivered Substantial Weight Loss, Mobility Improvement in Phase 3 Trial Analyses	MT
05-13	Novo Nordisk Pauses Manufacturing Plans at Odense Site, Layoff 150 Workers	MT
05-13	Denmark's Novo Nordisk Halts Development of Manufacturing Facility in Odense	MT
05-13	Novo Nordisk halts Odense construction and issues layoff notices	FW
05-13	Novo Nordisk Says Trial of Wegovy Pill Shows Some Patients Achieve Nearly 22% Weight Loss	DJ
05-13	Novo Nordisk says Wegovy pill delivers 21.6% weight loss in early responders	RE
05-13	NOVO NORDISK : Jefferies reaffirms its Neutral rating	ZD
05-13	Novo Nordisk: Oral Wegovy yields over 21 percent weight loss in clinical trial	FW